Last edition
News about "Bliss GVS Pharma"
Bliss GVS Pharma gets three minor observations from US FDA for Palghar unit
The company will prepare a detailed response to the observations, which will be submitted to the US FDA within the stipulated timelines
Bliss GVS Pharma | 20/03/2023 | By Sudeep Soparkar | 1367
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members